- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 15 - Approaches to Managing the Diabetes Epidemic
Peter Salgo, MD; Jeffrey D. Dunn, PharmD, MBA; and Maria Lopes, MD, MS, discuss accountable care organizations and cost-effectiveness programs in diabetes.
Despite providing patients with a number of disease management tools, the United States has not yet gained control of the diabetes epidemic, explains Dr Dunn. He says that coordination between all stakeholders (eg, patient, provider, payer, managed care) is necessary. In addition to improvements in the coordination between stakeholders, risk stratification and personalized treatment modalities are also important.
Dr Lopes notes that better care will require a more individualized approach and patient motivation. Preventive measures are important because they reduce the long-term costs of care, she adds. As an example, Kari Uusinarkaus, MD, FAAFP, FNLA, highlights the need for patients to understand their food choices and to read nutrition labels.
Yehuda Handelsman, MD, FACP, FACE, FNLA, concludes the discussion by explaining how diabetes is a global concern, and discusses why it is important to recognize preventive measures that other countries, such as China, are implementing to reduce the number of diabetes diagnoses.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More
Makers of medical tests will have about 4 years to show the FDA that their new offerings deliver accurate results; after previously decreasing for 27 years, US tuberculosis (TB) cases increased every year since 2020; a US district judge rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to the Medicare drug price negotiation program.
Read More
